Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M366Revenue (TTM) $M15.8Net Margin (%)-1,908.4Altman Z-Score-3.5
Enterprise Value $M382EPS (TTM) $-1.1Operating Margin %-1,859.8Piotroski F-Score1
P/E(ttm)--Beneish M-Score-8.5Pre-tax Margin (%)-1,908.4Higher ROA y-yN
Price/Book7.310-y EBITDA Growth Rate %6.5Quick Ratio4.7Cash flow > EarningsY
Price/Sales22.95-y EBITDA Growth Rate %17.2Current Ratio4.7Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-63.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-150.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M271ROIC % (ttm)-442.8Gross Margin Increase y-yN

Gurus Latest Trades with NVAX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NVAXGeorge Soros 2016-06-30 Sold Out $4.33 - $7.27
($5.72)
$ 1.35-76%Sold Out0
NVAXGeorge Soros 2016-03-31 Buy $4.36 - $8.39
($5.42)
$ 1.35-75%New holding30,300
NVAXJoel Greenblatt 2015-12-31 Sold Out -0.01%$6.59 - $8.77
($7.73)
$ 1.35-83%Sold Out0
NVAXJoel Greenblatt 2015-09-30 Buy 0.01%$6.41 - $14.14
($11.21)
$ 1.35-88%New holding110,640
NVAXFirst Eagle Investment 2014-12-31 Sold Out -0.0052%$4.05 - $5.98
($5.25)
$ 1.35-74%Sold Out0
NVAXFirst Eagle Investment 2014-06-30 Add$3.69 - $5.13
($4.39)
$ 1.35-69%Add 150.00%500,000
NVAXDavid Swensen 2014-03-31 Sold Out -0.23%$4.13 - $6.65
($5.59)
$ 1.35-76%Sold Out0
NVAXFirst Eagle Investment 2014-03-31 Reduce-0.01%$4.13 - $6.65
($5.59)
$ 1.35-76%Reduce -75.00%200,000
NVAXDavid Swensen 2013-12-31 Buy 0.23%$2.76 - $5.16
($3.51)
$ 1.35-62%New holding25,398
NVAXGeorge Soros 2013-12-31 Sold Out -0.02%$2.76 - $5.16
($3.51)
$ 1.35-62%Sold Out0
NVAXGeorge Soros 2013-09-30 Buy 0.02%$2.25 - $3.39
($2.82)
$ 1.35-52%New holding573,000
NVAXFirst Eagle Investment 2013-09-30 Buy 0.01%$2.25 - $3.39
($2.82)
$ 1.35-52%New holding800,000
NVAXFirst Eagle Investment 2011-03-31 Sold Out $2.15 - $2.96
($2.44)
$ 1.35-45%Sold Out0
NVAXFirst Eagle Investment 2010-09-30 Add$2.01 - $2.34
($2.2)
$ 1.35-39%Add 25.00%125,000
NVAXFirst Eagle Investment 2010-06-30 Reduce$2.18 - $2.97
($2.46)
$ 1.35-45%Reduce -52.65%100,000
NVAXFirst Eagle Investment 2009-12-31 Buy 0.01%$2.53 - $4.41
($3.46)
$ 1.35-61%New holding250,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NVAX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


NVAX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Glenn Gregory MPresident, R&D 2016-12-07Buy1,000$1.45-6.9view
Trizzino JohnSVP, Commercial Operations 2016-09-22Buy46,000$2.17-37.79view
DOUGLAS RICHARDDirector 2016-09-21Buy100,000$1.72-21.51view
MCMANUS MICHAEL A JRDirector 2016-09-21Buy30,000$1.61-16.15view
Glenn Gregory MPresident, R&D 2016-09-21Buy1,000$1.65-18.18view
BOUDREAUX GAILDirector 2016-09-20Buy100,000$1.45-6.9view
PHILLIPS BARCLAY ASVP, CFO 2016-07-31Buy422$4.29-68.53view
EVANS GARY CDirector 2016-06-06Sell18,998$6.5-79.23view
EVANS GARY CDirector 2016-05-24Sell50,000$5.41-75.05view
Erck Stanley CPresident and CEO 2016-03-31Sell424,778$5.19-73.99view

Quarterly/Annual Reports about NVAX:

News about NVAX:

Articles On GuruFocus.com
Weekly CFO Buys Highlight: United States Steel Corp, Tuesday Morning Corp, Novavax Inc. Feb 08 2015 
Novavax Inc. Reports Operating Results (10-Q) Nov 08 2010 
Novavax Inc. Reports Operating Results (10-Q) Aug 06 2010 
Novavax Inc. Reports Operating Results (10-Q) May 10 2010 
Novavax Inc. Reports Operating Results (10-Q) Nov 09 2009 
Novavax Inc. Reports Operating Results (10-Q) Aug 10 2009 
Novavax Inc. Reports Operating Results (10-Q) May 11 2009 

More From Other Websites
Novavax starts new clinical trial in bid to prove failed RSV vaccine Jan 19 2017
Novavax Initiates Phase 2 Safety and Immunogenicity Trial of the RSV F Vaccine in Older Adults Jan 19 2017
Novavax Initiates Phase 2 Safety and Immunogenicity Trial of the RSV F Vaccine in Older Adults Jan 19 2017
In Honor Of Friday The 13th, Here Are Some Of The Unluckiest Trades Of 2016 Jan 13 2017
D.C.-area biotech stocks fall on Trump's tough talk on industry Jan 11 2017
Novavax, Inc. – Value Analysis (NASDAQ:NVAX) : January 10, 2017 Jan 10 2017
Novavax, Inc. breached its 50 day moving average in a Bullish Manner : NVAX-US : January 9, 2017 Jan 09 2017
5 Stocks Setting Up for Big Breakouts Jan 06 2017
Novavax to Present at the 35th Annual J.P. Morgan Healthcare Conference Jan 05 2017
Novavax to Present at the 35th Annual J.P. Morgan Healthcare Conference Jan 05 2017
Genocea Announces Positive 6-Month Results from GEN-003 Phase 2b Clinical Trial Jan 05 2017
ETFs with exposure to Novavax, Inc. : January 3, 2017 Jan 03 2017
Are Options Traders Betting on a Big Move in Novavax (NVAX) Stock? Dec 28 2016
ETFs with exposure to Novavax, Inc. : December 21, 2016 Dec 21 2016
Novavax, Inc. breached its 50 day moving average in a Bullish Manner : NVAX-US : December 21, 2016 Dec 21 2016
Why Novavax (NVAX) Stock Might be a Great Pick Dec 13 2016
Here is What Hedge Funds Think About Novavax, Inc. (NVAX) Dec 07 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)